BPC-157
Preclinical — Animal / cell-model data onlyWhat it is
A synthetic 15-amino-acid sequence derived from a protein found in gastric juice. Almost all published data is preclinical.
BPC-157 is a synthetic 15-amino-acid sequence derived from a gastric protein, studied extensively in animals for tendon, ligament and gut healing. Human trial evidence is minimal.
Research context
Studied in relation to:
- Tendon/ligament repair (animal)
- Gut & GI support (animal)
- Soft-tissue recovery
Points in its favour in the literature:
- Large promising animal research base
- Generally well tolerated in studies
- Reported fast recovery response
Caveats and unknowns:
- Almost no controlled human trial data
- Not approved for human use anywhere
- Prohibited in sport (WADA)
- Purity varies by supplier
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature. In animal work it is often given near the target tissue.
Reported half-lifeshort
Published clinical / research context (not instructions)Commonly reported in research at ~200–500 mcg, once or twice daily.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 10 mg vial + 2 mL → 5 mg/mL (5000 mcg/mL).
Available research formats
| Strength | SKU |
|---|---|
| 5mg | BC5 |
| 10mg | BC10 |
| 20mg | BC20 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.